Skip to main content
Terug
Watch Compare

DSwiss Inc

Datakwaliteit: 100%
DQWS
OTC Manufacturing Chemicals
€ 0,03
▼ € 0,06 (-69,41%)
Marktkapitalisatie: 17,48 M
6 months return
Momentum
Neutral
5Y revenue growth
10,51%

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue grew 10,51% annually over 5 years — strong growth
Earnings declined -445,86% over the past year
Negative free cash flow of -135.334,0
Revenue growth is decelerating — 1Y growth trails 5Y average by 16,67%
Capital efficient — spends only 1,40% of revenue on capex

Price History

Groei

Revenue Growth (5Y)
10,51%
Boven sectorgemiddelde (1,72%)
Revenue (1Y)-6,16%
Earnings (1Y)-445,86%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-38,56%
Boven sectorgemiddelde (-54,44%)
ROIC-0,21%
Net Margin-2,63%
Op. Margin-0,04%

Veiligheid

Debt / Equity
N/A
Current Ratio1,09
Interest CoverageN/A

Waardering

PE (TTM)
-227,47
Onder sectorgemiddelde (-1,49)
P/B Ratio117,66
EV/EBITDA273,04
Dividend YieldN/A

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -227,5 -1,5
P/B 117,7 1,6
ROE % -38,6 -54,4
Net Margin % -2,6 -41,5
Rev Growth 5Y % 10,5 1,7
D/E 0,3

Koersdoel Analisten

Consensus van analisten: gemiddeld koersdoel vs huidige prijs en beoordeling.

Geen analistendekking beschikbaar

Winstschattingen

Analistprognoses voor EPS en omzet per periode. Jaar = boekjaren; kwartaal = komende kwartalen.

Periode WPA Sch. Omzet Sch. Analisten
FY2026 3,23 M

All Fundamental Metrics

Growth
Revenue Growth (1Y) -6,16% Revenue Growth (3Y) 40,96%
Earnings Growth (1Y) -445,86% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10,51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,92 M Net Income (TTM) -76.860,0
ROE -38,56% ROA -8,77%
Gross Margin 19,33% Operating Margin -0,04%
Net Margin -2,63% Free Cash Flow (TTM) -135.334,0
ROIC -0,21% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,09
Interest Coverage N/A Asset Turnover 3,33
Working Capital 36.597 Tangible Book Value 147.972
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -227,47 Forward P/E N/A
P/B Ratio 117,66 P/S Ratio 5,99
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 273,04 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,77%
Market Cap 17,48 M Enterprise Value 17,12 M
Per Share
EPS (Diluted TTM) 0,00 Revenue / Share 0,01
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) -500,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,40% FCF Conversion 176,08%
SBC-Adj. FCF N/A Growth Momentum -16,67

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,92 M 3,11 M 1,47 M 1,85 M 1,96 M
Net Income -76.860,0 22.223,0 -49.535,0 -2.937,0 150.102,0
EPS (Diluted) 0,00 0,00 0,00
Gross Profit 564.562,0 623.271,0 359.225,0 444.993,0 499.124,0
Operating Income -1.167,0 -1.203,0 -1.342,0 -1.303,0 -1.464,0
EBITDA
R&D Expenses
SG&A Expenses 630.645,0 603.720,0 367.647,0 402.412,0 308.686,0
D&A 63.854,0 17.558,0 64.933,0 72.441,0 19.946,0
Interest Expense
Income Tax 15.972,0 7.878,0 657,0 516,0 176,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 677.136,0 635.830,0 367.493,0 381.924,0 498.311,0
Total Liabilities 686.482,0 561.794,0 311.078,0 283.773,0 424.302,0
Shareholders' Equity -9.346,0 74.036,0 56.415,0 86.268,0 73.420,0
Total Debt
Cash & Equivalents 285.034,0 397.476,0 249.110,0 214.269,0 234.546,0
Current Assets 331.773,0 497.662,0 316.961,0 261.738,0 308.237,0
Current Liabilities 465.464,0 484.017,0 295.113,0 245.312,0 318.911,0